ARCHIVES

Bristol-Myers Adds Georgetown, MSK to Program

This article is from The Cancer Letter archive.

Vol. 07 No. 18 | May 1, 1981

Download PDF Visit The Full Archive

Related Articles

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set

August 11, 1978

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006